celecoxib has been researched along with Bronchopulmonary Dysplasia in 1 studies
Bronchopulmonary Dysplasia: A chronic lung disease developed after OXYGEN INHALATION THERAPY or mechanical ventilation (VENTILATION, MECHANICAL) usually occurring in certain premature infants (INFANT, PREMATURE) or newborn infants with respiratory distress syndrome (RESPIRATORY DISTRESS SYNDROME, NEWBORN). Histologically, it is characterized by the unusual abnormalities of the bronchioles, such as METAPLASIA, decrease in alveolar number, and formation of CYSTS.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Choo-Wing, R | 1 |
| Syed, MA | 1 |
| Harijith, A | 1 |
| Bowen, B | 1 |
| Pryhuber, G | 1 |
| Janér, C | 1 |
| Andersson, S | 1 |
| Homer, RJ | 1 |
| Bhandari, V | 1 |
1 other study available for celecoxib and Bronchopulmonary Dysplasia
| Article | Year |
|---|---|
Hyperoxia and interferon-γ-induced injury in developing lungs occur via cyclooxygenase-2 and the endoplasmic reticulum stress-dependent pathway.
Topics: Animals; Animals, Newborn; Bronchopulmonary Dysplasia; Celecoxib; Cell Death; Cyclooxygenase 2; Cycl | 2013 |